跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANOLAZINA ALTER 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANOLAZINA ALTER 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Approved
STANDARD
RANOLAZINA ALTER 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Laboratorios Alter S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 23, 2022
Approval ID
67fef3d6537255d5
Company
Laboratorios Alter S.A.
Type
Standard
Approval Details
Approval Id
67fef3d6537255d5
Drug Cima Aemps Name
RANOLAZINA ALTER 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number
88440
Holder Company Name
Laboratorios Alter S.A.
Marketing Company Name
Laboratorios Alter S.A.
Authorization Date
2022-12-23
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
500 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Alter S.A.
Active Ingredients
RANOLAZINA
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 23, 2022
Approval ID
67fef3d6537255d5
Type
Standard
Back to CIMA-AEMPS Approvals